Table 7 Main Biovac Institute (BI) capital expenditure items since public–private partnership (PPP) commencement in 2004
Year | Description | Costs (US$ million) | Contributed by |
|---|---|---|---|
2003 | Commencement costs for the PPP | 2.99 | Biovac Consortium (shareholders loan) |
2004 | Expansion of the cold room and warehouse (from 849 m2 to 1500 m2) | 1.00 | Biovac Consortium (shareholders loan) |
2006 | Quality control building and laboratories | 2.39 | Technology Innovation Agency (grant) |
2008 | Broad funding for BI to progress towards its target of becoming a vaccine manufacturer by 2013 | 2.56 | Technology Innovation Agency (grant) |
2009 | Warehouse building extension and new administration block | 4.76 | Industrial Development Corporation (loan) |
2011 | Construction of clean room | 14.82 | Istituto Superiore di Sanità and others (grant) |
2013 | Equipment for packaging, labelling and facility | 5.94 | Industrial Development Corporation (loan) |
2014 | Additional facilities to secure manufacturing contract for Rotavirus | 5.52 | Biovac Consortium (shareholders loan) |
Total | 39.99 |